FONAR Corporation (FONR)
NASDAQ: FONR · Real-Time Price · USD
15.60
+0.19 (1.23%)
At close: Jul 3, 2025, 1:00 PM
15.70
+0.10 (0.64%)
After-hours: Jul 3, 2025, 1:00 PM EDT
FONAR Market Cap
FONAR has a market cap or net worth of $98.22 million as of July 3, 2025. Its market cap has decreased by -2.75% in one year.
Market Cap
98.22M
Enterprise Value
84.70M
1-Year Change
-2.75%
Ranking
Category
Stock Price
$15.60
Market Cap Chart
Since December 1, 1998, FONAR's market cap has decreased from $107.60M to $98.22M, a decrease of -8.72%. That is a compound annual growth rate of -0.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 2, 2025 | 101.50M | 0.79% |
Dec 31, 2024 | 100.70M | -24.68% |
Dec 29, 2023 | 133.70M | 15.36% |
Dec 30, 2022 | 115.90M | 11.55% |
Dec 31, 2021 | 103.90M | -12.39% |
Dec 31, 2020 | 118.60M | -11.82% |
Dec 31, 2019 | 134.50M | -1.39% |
Dec 31, 2018 | 136.40M | -16.01% |
Dec 29, 2017 | 162.40M | 29.61% |
Dec 30, 2016 | 125.30M | 12.88% |
Dec 31, 2015 | 111.00M | 65.92% |
Dec 31, 2014 | 66.90M | -50.66% |
Dec 31, 2013 | 135.60M | 372.47% |
Dec 31, 2012 | 28.70M | 163.30% |
Dec 30, 2011 | 10.90M | 43.42% |
Dec 31, 2010 | 7.60M | -13.64% |
Dec 31, 2009 | 8.80M | 91.30% |
Dec 31, 2008 | 4.60M | -84.19% |
Dec 31, 2007 | 29.10M | -20.71% |
Dec 29, 2006 | 36.70M | -54.91% |
Dec 30, 2005 | 81.40M | -53.00% |
Dec 31, 2004 | 173.20M | 53.41% |
Dec 31, 2003 | 112.90M | 25.58% |
Dec 31, 2002 | 89.90M | 8.57% |
Dec 31, 2001 | 82.80M | -4.50% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 699.59B |
Johnson & Johnson | 374.29B |
AbbVie | 336.94B |
Novo Nordisk | 309.43B |
UnitedHealth Group | 279.00B |
Novartis AG | 243.28B |
Abbott Laboratories | 233.33B |
AstraZeneca | 219.33B |